Victoria Davis, MD
Obstetrics & Gynecology · Richmond, VANPI 1831181379
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.8% of the total across 288 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 41 manufacturers reported payments, led by AbbVie at 24.2% of the total. Among obstetrics & gynecology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Astellas Pharma US Inc$635
- Aspira Women's Health Inc$318
- Mayne Pharma Commercial LLC$314
- Myovant Sciences Inc.$303
- Biogen$297
- plus $3K from 35 others
What the payments were for
- Food & beverage$5,82494%
- Education$3836%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 75 | $1,500 |
| Astellas Pharma US Inc | 19 | $635 |
| Aspira Women's Health Inc | 5 | $318 |
| Mayne Pharma Commercial LLC | 19 | $314 |
| Myovant Sciences Inc. | 12 | $303 |
| Biogen | 12 | $297 |
| Pfizer | 17 | $252 |
| Organon | 13 | $242 |
| Novo Nordisk | 3 | $214 |
| Bayer | 11 | $187 |
| Coopersurgical, Inc. | 9 | $172 |
| Merck | 9 | $154 |
| Mylan Pharmaceuticals Inc. | 7 | $134 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $129 |
| Exeltis, USA Inc. | 8 | $128 |
| Biohaven Pharmaceuticals, Inc. | 3 | $123 |
| AMAG Pharmaceuticals, Inc. | 6 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $78 |
| Amgen | 4 | $77 |
| Hologic Sales And Service, LLC | 4 | $76 |
| Daiichi Sankyo Inc. | 3 | $74 |
| Shield Therapeutics Inc | 4 | $72 |
| Therapeuticsmd, Inc. | 5 | $67 |
| Johnson & Johnson | 3 | $59 |
| Millicent US Inc | 3 | $50 |
| Renovia Inc | 3 | $45 |
| Lupin Inc. | 3 | $44 |
| Mycovia Pharmaceuticals, Inc. | 3 | $41 |
| Vertical Pharmaceuticals, LLC | 3 | $36 |
| Scynexis, Inc. | 2 | $34 |
| Minerva Surgical, Inc | 2 | $33 |
| Agile Therapeutics, Inc. | 2 | $27 |
| Mimedx Group, Inc. | 1 | $27 |
| Evofem Biosciences, Inc. | 2 | $26 |
| Davol Inc. | 1 | $25 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Medicem Inc. | 1 | $22 |
| Duchesnay USA Incorporated | 1 | $21 |
| Exact Sciences | 1 | $17 |
| Avion Pharmaceuticals | 1 | $16 |
| Covidien LP | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,208 in reported general payments places this provider in the 95th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 135 | $8,194 |
| Estradiol (Twice Weekly)Estradiol | 44 | $4,511 |
| ProgesteroneProgesterone, Micronized | 85 | $3,229 |
| ValacyclovirValacyclovir Hcl | 42 | $2,321 |
| Acyclovir | 13 | $2,206 |
| Paroxetine Mesylate | 11 | $1,463 |
| Estradiol (Once Weekly)Estradiol | 14 | $1,110 |
| Oxybutynin Chloride ErOxybutynin Chloride | 22 | $769 |
| Metronidazole | 20 | $620 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 17 | $286 |
| Megestrol Acetate | 15 | $226 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $156 |
| Spironolactone | 17 | $124 |
| Fluconazole | 28 | $89 |
| Alprazolam | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Richmond
- James JonesRichmond$134K
- Nicole KarjaneRichmond$34K
- Lauren SiffRichmond$16K
- Christina IsaacsRichmond$11K
- Frances CaseyRichmond$11K
- Ramzi AboujaoudeRichmond$10K
- Karen KnappRichmond$9K
- Adrienne MaraistRichmond$6K
- Thomas KimbleNorfolk$286K
- Jack AyoubLeesburg$279K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.